期刊文献+

MR扩散张量成像在慢性肾病分期诊断中的价值 被引量:6

Primary study of chronic kidney disease with MR diffusion tensor imaging
原文传递
导出
摘要 目的 探讨MR扩散张量成像(DTI)在慢性肾病(CKD)分期诊断中的价值.方法 前瞻性收集26例符合临床CKD诊断标准,MR图像质量达到诊断要求,并行99m锝-二乙三胺五乙酸肾动态显像测定肾功能的患者,将患者按照CKD分期标准分为轻度肾损害组(12例)和中重度肾损害组(14例).收集同期20名志愿者作为对照组.所有受试者均行双肾MRI常规扫描和DTI检查,测量皮、髓质ADC及FA值.所有受试者肾皮、髓质间ADC值和FA值的比较采用配对样本t检验.3组受试者肾皮、髓质ADC值和FA值的比较采用单因素方差分析,两两比较采用LSD法.CKD患者肾脏皮、髓质ADC值及FA值与肾小球滤过率的相关性采用Pearson相关性分析.结果 46例受试者皮、髓质的ADC值分别为(2.25±0.25)×10-3和(2.10±0.20) ×103mm2/s,FA值分别为3.48±0.61和4.27±0.75,皮质和髓质的测量值差异均有统计学意义(t值分别为6.754和10.043,P值均<0.01).对照组、CKD轻度肾损害组、CKD中重度肾损害组肾皮质的ADC值分别为(2.25±0.22) ×10-3、(2.31±0.19) ×103和(2.18±0.32)×103mm2/s,肾髓质ADC值分别为(2.09±0.19)×10-3、(2.17±0.17)×10-3和(2.06±0.24)×10-3mm2/s,差异均无统计学意义(F值分别为0.968和0.882,P值均>0.05).上述3组肾皮质FA值分别为3.85±0.47、3.18±0.62和3.20±0.52,肾髓质分别为4.92±0.38、3.93±0.57和3.62±0.53,差异均有统计学意义(F值分别为8.725和33.705,P值均<0.01),两两比较对照组FA值均高于CKD两组(P值均<0.01).CKD患者皮、髓质ADC值及皮质的FA值与肾小球滤过率[(30.14±15.79) ml· min-1· 1.73 m-2]无相关性(r值分别为0.243、0.197及0.196,P值分别为0.231、0.334及0.337),仅髓质FA值与GFR呈正相关(r=0.556,P=0.003).结论 DTI能为CKD的分期诊断提供有价值的信息,肾髓质FA值测量可用于评价肾功能状态. Objective To study the value of MR diffusion tensor imaging(DTI) in the staging of chronic kidney disease(CKD).Method MR diffusion tensor imaging was used on 26 CKD patients.All patients were diagnosed as CKD according to the criteria of clinical diagnostic.All MR images achieved diagnostic requirements.Diethylenetriamine pentaacetic acid(99mTc-DTPA) renal dynamic imaging was used to determine the unilateral renal function.CKD patients were determined as mildly renal impairment group and moderately to severely renal impairment group based on the glomerular filtration rate(GFR).Twenty healthy volunteers underwent DTI at the same time.The cortical and medullary ADC value and FA value were measured in all subjects who underwent conventional MRI and DTI.The paired Student's t test was used to compare the cortico-medullary difference of the mean ADC and FA values in all subjects.The oneway analysis of variance(ANOVA) was carried out to assess the difference among the medullary and cortical diffusion parameters(ADC,FA) of all the three groups,and LSD was used to assess multiple comparisons.The correlation of GFR and ADC value of the patients,and FA value of the patients were tested by Pearson correlation analysis.Results The cortical and medullary ADC values of 46 subjects were(2.25±0.25) × 10-3 and(2.10±0.20) × 10-3 mm2/s respectively,FA of them were(3.48±0.61) and(4.27±0.75) respectively(t =6.754,10.043 respectively; P<0.01).The cortical ADC values of volunteers,mild renal impairment group,severely renal impairment group were(2.25±0.22) ×10-3,(2.31±0.19) ×103,(2.18±0.32) ×10-3mm2/s respectively.The medullary ADC value of the three groups were(2.09±0.19) × 10-3,(2.17±0.17) × 10-3,(2.06±0.24) × 10-3mm2/s respectively(F=0.968,0.882 respectively; P>0.05).The cortical FA values of the three groups were 3.85± 0.47,3.18±0.62,3.20±0.52 respectively.The medullary FA of the three groups were 4.92±0.38,3.93±0.57,3.62 ± 0.53(F=8.725,33.705 respectively; P<0.01).There was no correlation between cortical ADC,medullary ADC,cortical FA of the patients and GFR [(30.14±15.79) ml· min-1 · 1.73 m-2](r =0.243,0.197,0.196 respectively; P>0.05).There was a positive correlation between medullary FA of the patients and GFR (r=0.556,P=0.003).Conclusion FA value has certain value in evaluating CKD early diagnosis and renal function.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2014年第7期555-558,共4页 Chinese Journal of Radiology
基金 江西省卫生厅科技计划资助项目(20121057,20131067)
关键词 肾病 肾小球滤过率 磁共振成像 Nehphrosis Glomerular filtration rate Magnetic resonance imaging
  • 相关文献

参考文献1

二级参考文献17

  • 1周玉红 左力 王梅.MDRD方程预测肾小球滤过率的临床应用评价[J].中华肾脏病杂志,2004,20:30-34.
  • 2Carlsen O. The gamma camera as an absolute measurement device: determination of glomerular filtration rate in ^99mTc-DTPA renography using a dual head gamma camera. Nucl Med Commun, 2004, 25: 1021-1029.
  • 3Eknoyan G. Meeting the challenges of the new K/DOQ1 guidelines. Am J Kidney Dis, 2003, 41(5 Suppl):3-10.
  • 4Zuo L, Ma YC, Zhou YH, et al. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis, 2005, 45 : 463-472.
  • 5Levey AS. Measurement of renal function in chronic renal disease. Kidney Int, 1990, 38: 167-184.
  • 6Ham HR, Piepsz A. Clinical measurement of renal clearance.Curt Opin Nephrol Hypertens, 1992, 1:252-260.
  • 7Petersen LJ, Petersen JR, Talleruphuus U, et al.Glomendar filtration rate estimated from the uptake phase of ^99mTc-DTPA renography in chronic renal failure. Nephrol Dial Transplant, 1999, 14:1673-1678.
  • 8Blaufox MD, Aurell M, Bubeck B, et al. Report of the Radionuclides in Nephrourology Committee on renal clearance.J Nud Med, 1996, 37:1883-1890.
  • 9Gates GF. Glomerular flit.ration rate: estimation from fractional renal accumulation of ^99mTc-DTPA (starmous). AJR Am J Roentgenol, 1982, 138:565-570.
  • 10Delpassand ES, Homayoon K, Madden T, et al. Determination of glomerular filtration rate using a dual-detector gamma camera and the geometric mean of renal activity: correlation with the ^99mTc-DTPA plasma clearance method. Clin Nucl Med, 2000, 25:258-262.

共引文献52

同被引文献56

  • 1Munehiro Kitada,Keizo Kanasaki,Daisuke Koya.Clinical therapeutic strategies for early stage of diabetic kidney disease[J].World Journal of Diabetes,2014,5(3):342-356. 被引量:12
  • 2倪兆慧.透析患者中枢系统并发症的诊断和治疗[J].中国血液净化,2007,6(8):450-451. 被引量:3
  • 3Bansal VK, Bansal S. Nervous system disorders in dialysispatients[J].Handb Clin Neurol, 2014,119:395-404.
  • 4Griva K, Stygall J, Hankins M, et al. Cognitive impairmentand 7-year mortality in dialysis patients[J].Am J Kidney Dis,2010, 56(4):693-703.
  • 5Focke NK, Trost S,Paulus W, et al. Do manual andvoxel-based morphometry measure the same. A proof ofconcept study[J].Front Psychiatry,2014,5:39.
  • 6Prohovnik I, Post J, Uribarri J, et al. Cerebrovascular effectsof hemodialysis in chronic kidney disease[J].J Cereb BloodFlow Metab, 2007,27(11):1861-1869.
  • 7Zhang U, Wen J, Ni L, et al. Predominant gray mattervolume loss in patients with end-stage renal disease: avoxel-based morphometry study[J].Metab Brain Dis, 2013, 28(4):647-654.
  • 8Drew DA, Bhadelia R,Tighiouart H, et al. Anatomic braindisease in hemodialysis patients: a cross-sectional study[J].Am J Kidney Dis, 2013,61(2):271-278.
  • 9Fazekas G, Fazekas F,Schmidt R, et al. Brain MRI findingsand cognitive impairment in patients undergoing chronichemodialysis treatment[J].J Neurol Sci, 1995,134(1-2):83-88.
  • 10Hermann DM, Kribben A, Bruck H. Cognitive impairment inchronic kidney disease: clinical findings, risk factors andconsequences for patient care[J].J Neural Transm, 2014,121.

引证文献6

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部